Restorative and health-Enhancing Sleep Time (REST)
National Institutes of Health · ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation ARPA-H-SOL-26-159 in this department, oldest first.
- Jun 16, 2026SolicitationOpen
- Jun 16, 2026SolicitationOpen
- Jun 17, 2026SolicitationOpen
- Jun 18, 2026SolicitationOpen
- Jun 24, 2026SolicitationOpen
- Jul 7, 2026SolicitationOpen
- Jul 16, 2026SolicitationOpen
- Aug 10, 2026SolicitationOpen
- Aug 11, 2026SolicitationOpen
- Sep 14, 2026 · this noticeSolicitation
- Sep 14, 2026SolicitationOpen
- Sep 15, 2026SolicitationOpen
- Sep 21, 2026SolicitationOpen
- Oct 2, 2026SolicitationOpen
- Oct 5, 2026SolicitationOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
The Advanced Research Projects Agency for Health (ARPA-H) seeks proposals for the Restorative & health-Enhancing Sleep Time (REST) program, a bold effort to transform how poor sleep is measured and treated by enabling objective, home-based, closed-loop technologies that detect health-relevant sleep microstructures and respond to them in real time. If successful, REST will establish the technical foundation for a new generation of sleep health technologies that are objective, personalized, and capable of improving long-term health outcomes at scale. 6/16: Amendment 1 updates links within the IS… (show all)
O 6/18: Amendment 2 adds Section 6.5 Questions and Answers 6/24: Amendment 3 makes various edits for clarification in Sections 1-3. 7/7: Amendment 4 modifies the table in Section 3.2.1 TA1 Success Metrics. 7/16: Amendment 5 modifies additional text within the table in Section 3.2.1 TA1 Success Metrics. 8/10: Amendment 6 modifies the solicitation by breaking the Solution Summary, Proposal and Pitch into distinct categories. Solution Summaries will be reviewed on an encourage/discourage basis; Proposals will be evaluated on an invite/not invited basis; Pitches will be evaluated on a selected for negotiation/not selected basis. 8/11: Amendment 7 modifies Section 3.3 Key Program Milestones table. Changes made in Amendment 6 remain in red text to highlight important changes to solicitation process.
Who won similar work
58 award notices on SAM.gov in the last 24 months. Matched by: Same agency (National Institutes of Health), same NAICS 541715.
Single-winner award sizes (45): middle half $4.9M to $35.0M, median $17.1M; range $10K to $79.3M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| DUKE UNIVERSITY Durham NC 27705 USA | 2 | $36.3M | Mar 31, 2025 |
| The TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 630 WEST 168TH STREET BOX 49 NEW YORK NY 10032 USA | 2 | $17.1M + 1 shared | Sep 25, 2026 |
| Northwestern University 750 N. LAKE SHORE DRIVE RUBLOFF 7TH FLOOR CHICAGO IL 60611 USA | 2 | $7.7M + 1 shared | Apr 10, 2025 |
| WAKE FOREST UNIVERSITY HEALTH SCIENCES MEDICAL CENTER BLVD. Winston Salem NC 27157 USA | 2 | $4.9M + 1 shared | Apr 10, 2025 |
| SCIOME LLC | 1 | $79.3M | Aug 27, 2026 |
| UNIVERSITY OF MISSISSIPPI MEDICAL CENTER Jackson MS 39216 USA | 1 | $63.9M | Sep 15, 2025 |
| TEMPUS AI, INC · $TEM · $531.8M | 1 | $60.6M | Sep 17, 2025 |
| UNIVERSITY OF WASHINGTON 4333 BROOKLYN AVENUE NE BOX 359472 Seattle WA 98195 USA | 1 | $55.5M | Apr 10, 2025 |
| WAKE FOREST UNIVERSITY HEALTH SCIENCES Winston Salem NC 27157 USA | 1 | $49.5M | Sep 15, 2025 |
| FISHER BIOSERVICES INC | 1 | $48.0M | Oct 7, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $TEM reported $531.8M revenue in FY2025. The median single-winner award in these 45 past awards, $17.1M, is 3% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 7, 2026AMERICAN TYPE CULTURE COLLECTION Manassas VA 20110 USA$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASES
- Oct 7, 2026ADVANCED BIOSCIENCE LABORATORIES, INC.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASES
- Oct 7, 2026BCG FEDERAL CORP.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASES
- Oct 7, 2026SIA PARTNERS U.S., INC.$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASES
- Oct 7, 2026FISHER BIOSERVICES INC$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASES
- Oct 7, 2026PPD DEVELOPMENT LP$48.0MVACCINE (AND OTHER BIOLOGIC) MANUFACTURING SERVICES FOR INFECTIOUS DISEASES
- Sep 28, 2026EMORY UNIVERSITY 1599 CLIFTON ROAD NE 4TH FLOOR MAILSTOP 1599-001-1BA Atlanta GA 30322 USA$7.4M (shared ceiling)A--Recipient Epidemiology and Donor Evaluation Study
- Sep 28, 2026Versiti Blood Health, Inc.$7.4M (shared ceiling)A--Recipient Epidemiology and Donor Evaluation Study
- Sep 25, 2026WESTAT, INC.$21.4MA--REDS-V-Data Coordinating Center
- Sep 25, 2026The TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 630 WEST 168TH STREET BOX 49 NEW YORK NY 10032 USA$7.4M (shared ceiling)A--Recipient Epidemiology and Donor Evaluation Study
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
- 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 21 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.